Login Get Started
Browse
Shares
Healthcare
Biotechnology & Medical Research
Veracyte Inc
Veracyte Inc logo

VCYT - Veracyte Inc Share News

$47.51 0.6  1.3%

Last Trade - 05/03/21

Sector
Healthcare
RiskRating
Adventurous
Size
Mid Cap
Style
Style Neutral
Market Cap £2.30bn
Enterprise Value £2.05bn
Revenue £84.9m
Position in Universe 1764th / 6651
Quality
Value
Momentum
StockRank™
StockReport™
Tools
Compare with... Run through checklist
Accounts
Balance sheet Income statement Cashflow statement Dividend summary
Charts News Discussions VCYT Dividends
All News
All News Reuters News Company Announcements
BRIEF-Veracyte Reports Q2 Loss Per Share $0.22
30th Jul '20 News
BRIEF-Veracyte and MAVIDx Announce Agreement to Develop High Volume COVID-19 Testing
29th Jul '20 News
BRIEF-Veracyte Announces De Novo Classification Request To FDA For The Ncounter Dx Lymphmark Assay
9th Jun '20 News
BRIEF-Caredx And Veracyte Announce Partnership For Transplant Rejection Testing On Ncounter System
14th May '20 News
BRIEF-Veracyte And Yale Announce Exclusive License To Advance First Genomic Monitoring Test For Idiopathic Pulmonary Fibrosis
23rd Apr '20 News
BRIEF-Veracyte Reports Prelim Q1 2020 Financial Results
16th Apr '20 News
BRIEF-Veracyte Announces Novel Gene Fusion Detection With Afirma Xpression Atlas
1st Apr '20 News
BRIEF-Veracyte Announces Biopharmaceutical Collaboration With Acerta Pharma
8th Jan '20 News
BRIEF-Veracyte Acquires Exclusive License To Nanostring Diagnostics Platform, Positioning Veracyte To Expand Genomic Testing Business
3rd Dec '19 News
BRIEF-Veracyte Reports Q3 Loss Per Share Of $0.02
22nd Oct '19 News
BRIEF-Veracyte Announces Clinical Data Demonstrating Clinical Validity And Utility Of Percepta Classifier
21st Oct '19 News
BRIEF-Veracyte Announces New Data Demonstrating That Envisia Genomic Classifier Improves IPF Diagnosis
21st Oct '19 News
BRIEF-Veracyte Q2 Loss Per Share $0.05
30th Jul '19 News
BRIEF-Veracyte Names Keith Kennedy Chief Operating Officer And Chief Financial Officer
1st Jul '19 News
BRIEF-Veracyte Appoints Keith Kennedy To Serve As Chief Operating Officer
28th Jun '19 News
BRIEF-Veracyte's Percepta Genomic Sequencing Classifier Now Available To Physicians For Lung Cancer Diagnosis
26th Jun '19 News
BRIEF-Veracyte Announces New Publication of Data Demonstrating Real-World Performance of the Afirma GSC in Thyroid Cancer Diagnosis
10th Jun '19 News
BRIEF-Veracyte Announces Pricing Of Public Offering Of 5,500,000 Shares Of Common Stock
3rd May '19 News
BRIEF-Veracyte Inc Files For Potential Mixed Shelf Offering
1st May '19 News
BRIEF-Veracyte Announces Proposed Public Offering Of Common Stock
1st May '19 News
© Stockopedia 2021, Refinitiv, Share Data Services.
Youtube Instagram RSS
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.